Interstitial pneumonia microenvironment promotes metastasis to the mediastinal lymph nodes and lungs Article Swipe
Ryo Maeda
,
Mayu Inomata
,
Ryusei Yamada
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2025.1657948
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fonc.2025.1657948
Introductionhta The prognosis of patients with lung cancer and interstitial lung disease (ILD) is worse than that of patients without ILDs; however, therapeutic options for ILD-associated lung cancer are severely limited. Although ILD is associated with an increased incidence of lung cancer, it is unclear whether the ILD lung environment affects the biological behavior of lung cancer. Methods We tested our hypothesis that the lung environment of ILD is associated with the biological behavior and progression of lung cancer using an in vivo murine model of interstitial pneumonia (IP) and lung cancer. Results The bleomycin-induced IP lung environment promoted metastasis to the mediastinal lymph nodes or contralateral lungs in an orthotopic model of lung cancer. The results of our in vivo experiments were supported by clinical data, which indicated that a significantly greater number of carcinomas with vascular invasion and lymphatic permeation, lymph node metastases, and intrapulmonary metastases were found in patients with clinical stage I non-small cell lung cancer and ILD than in those without ILD. In addition, pharmacological treatment of the IP lung environment with pirfenidone (PFD) inhibited tumor progression in the IP lung cancer model. Conclusion We found that the IP lung environment promotes lung cancer metastasis. The results of this study may pave the way for further clinical studies on the use of PFD alone or in conjunction with conventional chemotherapy in patients with lung cancer and ILD.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fonc.2025.1657948
- https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdf
- OA Status
- gold
- References
- 39
- OpenAlex ID
- https://openalex.org/W4415135212
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415135212Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fonc.2025.1657948Digital Object Identifier
- Title
-
Interstitial pneumonia microenvironment promotes metastasis to the mediastinal lymph nodes and lungsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-14Full publication date if available
- Authors
-
Ryo Maeda, Mayu Inomata, Ryusei YamadaList of authors in order
- Landing page
-
https://doi.org/10.3389/fonc.2025.1657948Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
39Number of works referenced by this work
Full payload
| id | https://openalex.org/W4415135212 |
|---|---|
| doi | https://doi.org/10.3389/fonc.2025.1657948 |
| ids.doi | https://doi.org/10.3389/fonc.2025.1657948 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41164139 |
| ids.openalex | https://openalex.org/W4415135212 |
| fwci | 0.0 |
| type | article |
| title | Interstitial pneumonia microenvironment promotes metastasis to the mediastinal lymph nodes and lungs |
| biblio.issue | |
| biblio.volume | 15 |
| biblio.last_page | 1657948 |
| biblio.first_page | 1657948 |
| topics[0].id | https://openalex.org/T10870 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| topics[1].id | https://openalex.org/T11026 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9968000054359436 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Occupational and environmental lung diseases |
| topics[2].id | https://openalex.org/T11356 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9962999820709229 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Pleural and Pulmonary Diseases |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| language | en |
| locations[0].id | doi:10.3389/fonc.2025.1657948 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2596394214 |
| locations[0].source.issn | 2234-943X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2234-943X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Oncology |
| locations[0].landing_page_url | https://doi.org/10.3389/fonc.2025.1657948 |
| locations[1].id | pmid:41164139 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41164139 |
| locations[2].id | pmh:oai:doaj.org/article:27013190cfac410caefa9fd8ddbb34f5 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Oncology, Vol 15 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/27013190cfac410caefa9fd8ddbb34f5 |
| locations[3].id | pmh:oai:europepmc.org:11368110 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12558802 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5069799858 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7223-8817 |
| authorships[0].author.display_name | Ryo Maeda |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I118574687 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| authorships[0].institutions[0].id | https://openalex.org/I118574687 |
| authorships[0].institutions[0].ror | https://ror.org/0447kww10 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I118574687 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | University of Miyazaki |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ryo Maeda |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| authorships[1].author.id | https://openalex.org/A5031024576 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Mayu Inomata |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I118574687 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I118574687 |
| authorships[1].institutions[0].ror | https://ror.org/0447kww10 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I118574687 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | University of Miyazaki |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mayu Inomata |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| authorships[2].author.id | https://openalex.org/A5112926401 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Ryusei Yamada |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I118574687 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I118574687 |
| authorships[2].institutions[0].ror | https://ror.org/0447kww10 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I118574687 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | University of Miyazaki |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Ryusei Yamada |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-14T00:00:00 |
| display_name | Interstitial pneumonia microenvironment promotes metastasis to the mediastinal lymph nodes and lungs |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10870 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fonc.2025.1657948 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2596394214 |
| best_oa_location.source.issn | 2234-943X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2234-943X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fonc.2025.1657948 |
| primary_location.id | doi:10.3389/fonc.2025.1657948 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2596394214 |
| primary_location.source.issn | 2234-943X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2234-943X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1657948/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Oncology |
| primary_location.landing_page_url | https://doi.org/10.3389/fonc.2025.1657948 |
| publication_date | 2025-10-14 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W1970902896, https://openalex.org/W2416914730, https://openalex.org/W1770545381, https://openalex.org/W2160431037, https://openalex.org/W1988781537, https://openalex.org/W2885464847, https://openalex.org/W3196575932, https://openalex.org/W1998778854, https://openalex.org/W1993946952, https://openalex.org/W1966561569, https://openalex.org/W1971493000, https://openalex.org/W2083819985, https://openalex.org/W2135733194, https://openalex.org/W1975073272, https://openalex.org/W2051387822, https://openalex.org/W2520163688, https://openalex.org/W2997687014, https://openalex.org/W2781029361, https://openalex.org/W2787449173, https://openalex.org/W2102634410, https://openalex.org/W2492095263, https://openalex.org/W2039685773, https://openalex.org/W2138153375, https://openalex.org/W2032585979, https://openalex.org/W2075400164, https://openalex.org/W2123901563, https://openalex.org/W2606309368, https://openalex.org/W1993559550, https://openalex.org/W4388484248, https://openalex.org/W4223502512, https://openalex.org/W4379209546, https://openalex.org/W4319456746, https://openalex.org/W2920483428, https://openalex.org/W2461182554, https://openalex.org/W2168666423, https://openalex.org/W3003058300, https://openalex.org/W1860863518, https://openalex.org/W2134164289, https://openalex.org/W4226382697 |
| referenced_works_count | 39 |
| abstract_inverted_index.I | 155 |
| abstract_inverted_index.a | 130 |
| abstract_inverted_index.IP | 95, 173, 184, 193 |
| abstract_inverted_index.In | 167 |
| abstract_inverted_index.We | 58, 189 |
| abstract_inverted_index.an | 36, 80, 109 |
| abstract_inverted_index.by | 124 |
| abstract_inverted_index.in | 81, 108, 119, 150, 163, 182, 220, 225 |
| abstract_inverted_index.is | 13, 33, 43, 68 |
| abstract_inverted_index.it | 42 |
| abstract_inverted_index.of | 3, 17, 39, 54, 66, 76, 85, 112, 117, 134, 171, 202, 216 |
| abstract_inverted_index.on | 213 |
| abstract_inverted_index.or | 105, 219 |
| abstract_inverted_index.to | 100 |
| abstract_inverted_index.ILD | 32, 47, 67, 161 |
| abstract_inverted_index.PFD | 217 |
| abstract_inverted_index.The | 1, 93, 115, 200 |
| abstract_inverted_index.and | 8, 74, 89, 139, 145, 160, 230 |
| abstract_inverted_index.are | 28 |
| abstract_inverted_index.for | 24, 209 |
| abstract_inverted_index.may | 205 |
| abstract_inverted_index.our | 60, 118 |
| abstract_inverted_index.the | 46, 51, 63, 71, 101, 172, 183, 192, 207, 214 |
| abstract_inverted_index.use | 215 |
| abstract_inverted_index.way | 208 |
| abstract_inverted_index.(IP) | 88 |
| abstract_inverted_index.ILD. | 166, 231 |
| abstract_inverted_index.cell | 157 |
| abstract_inverted_index.lung | 6, 10, 26, 40, 48, 55, 64, 77, 90, 96, 113, 158, 174, 185, 194, 197, 228 |
| abstract_inverted_index.node | 143 |
| abstract_inverted_index.pave | 206 |
| abstract_inverted_index.than | 15, 162 |
| abstract_inverted_index.that | 16, 62, 129, 191 |
| abstract_inverted_index.this | 203 |
| abstract_inverted_index.vivo | 82, 120 |
| abstract_inverted_index.were | 122, 148 |
| abstract_inverted_index.with | 5, 35, 70, 136, 152, 176, 222, 227 |
| abstract_inverted_index.(ILD) | 12 |
| abstract_inverted_index.(PFD) | 178 |
| abstract_inverted_index.ILDs; | 20 |
| abstract_inverted_index.alone | 218 |
| abstract_inverted_index.data, | 126 |
| abstract_inverted_index.found | 149, 190 |
| abstract_inverted_index.lungs | 107 |
| abstract_inverted_index.lymph | 103, 142 |
| abstract_inverted_index.model | 84, 111 |
| abstract_inverted_index.nodes | 104 |
| abstract_inverted_index.stage | 154 |
| abstract_inverted_index.study | 204 |
| abstract_inverted_index.those | 164 |
| abstract_inverted_index.tumor | 180 |
| abstract_inverted_index.using | 79 |
| abstract_inverted_index.which | 127 |
| abstract_inverted_index.worse | 14 |
| abstract_inverted_index.cancer | 7, 27, 78, 159, 186, 198, 229 |
| abstract_inverted_index.model. | 187 |
| abstract_inverted_index.murine | 83 |
| abstract_inverted_index.number | 133 |
| abstract_inverted_index.tested | 59 |
| abstract_inverted_index.Methods | 57 |
| abstract_inverted_index.Results | 92 |
| abstract_inverted_index.affects | 50 |
| abstract_inverted_index.cancer, | 41 |
| abstract_inverted_index.cancer. | 56, 91, 114 |
| abstract_inverted_index.disease | 11 |
| abstract_inverted_index.further | 210 |
| abstract_inverted_index.greater | 132 |
| abstract_inverted_index.options | 23 |
| abstract_inverted_index.results | 116, 201 |
| abstract_inverted_index.studies | 212 |
| abstract_inverted_index.unclear | 44 |
| abstract_inverted_index.whether | 45 |
| abstract_inverted_index.without | 19, 165 |
| abstract_inverted_index.Although | 31 |
| abstract_inverted_index.behavior | 53, 73 |
| abstract_inverted_index.clinical | 125, 153, 211 |
| abstract_inverted_index.however, | 21 |
| abstract_inverted_index.invasion | 138 |
| abstract_inverted_index.limited. | 30 |
| abstract_inverted_index.patients | 4, 18, 151, 226 |
| abstract_inverted_index.promoted | 98 |
| abstract_inverted_index.promotes | 196 |
| abstract_inverted_index.severely | 29 |
| abstract_inverted_index.vascular | 137 |
| abstract_inverted_index.addition, | 168 |
| abstract_inverted_index.incidence | 38 |
| abstract_inverted_index.increased | 37 |
| abstract_inverted_index.indicated | 128 |
| abstract_inverted_index.inhibited | 179 |
| abstract_inverted_index.lymphatic | 140 |
| abstract_inverted_index.non-small | 156 |
| abstract_inverted_index.pneumonia | 87 |
| abstract_inverted_index.prognosis | 2 |
| abstract_inverted_index.supported | 123 |
| abstract_inverted_index.treatment | 170 |
| abstract_inverted_index.Conclusion | 188 |
| abstract_inverted_index.associated | 34, 69 |
| abstract_inverted_index.biological | 52, 72 |
| abstract_inverted_index.carcinomas | 135 |
| abstract_inverted_index.hypothesis | 61 |
| abstract_inverted_index.metastases | 147 |
| abstract_inverted_index.metastasis | 99 |
| abstract_inverted_index.orthotopic | 110 |
| abstract_inverted_index.conjunction | 221 |
| abstract_inverted_index.environment | 49, 65, 97, 175, 195 |
| abstract_inverted_index.experiments | 121 |
| abstract_inverted_index.mediastinal | 102 |
| abstract_inverted_index.metastases, | 144 |
| abstract_inverted_index.metastasis. | 199 |
| abstract_inverted_index.permeation, | 141 |
| abstract_inverted_index.pirfenidone | 177 |
| abstract_inverted_index.progression | 75, 181 |
| abstract_inverted_index.therapeutic | 22 |
| abstract_inverted_index.chemotherapy | 224 |
| abstract_inverted_index.conventional | 223 |
| abstract_inverted_index.interstitial | 9, 86 |
| abstract_inverted_index.contralateral | 106 |
| abstract_inverted_index.significantly | 131 |
| abstract_inverted_index.ILD-associated | 25 |
| abstract_inverted_index.intrapulmonary | 146 |
| abstract_inverted_index.Introductionhta | 0 |
| abstract_inverted_index.pharmacological | 169 |
| abstract_inverted_index.bleomycin-induced | 94 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5069799858 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 3 |
| corresponding_institution_ids | https://openalex.org/I118574687 |
| citation_normalized_percentile.value | 0.65361138 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |